Clinicopathological characteristics and outcomes in patients with lung metastases from differentiated thyroid carcinoma following 131I therapy

被引：0
|
作者：
Sun Yungang [1 ]
Ouyang, Wei [1 ]
Feng, Huijuan [1 ]
Wu, Juqing [1 ]
Chen, Pan [1 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Nucl Med, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1471
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of frequency of lung metastases from differentiated thyroid carcinoma and response to 131I therapy
    Kalender, Ebuzer
    Celen, Y. Zeki
    Elboga, Umut
    Demir, Hasan Deniz
    Yilmaz, Mustafa
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [2] 131I treatment for brain metastases from differentiated thyroid carcinoma
    YU Yong-Li
    [J]. Nuclear Science and Techniques, 2004, (04) : 223 - 226
  • [3] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [4] Analysis of the 131I therapy in the young and adolescent patients with differentiated thyroid carcinoma
    Wang, Jiantao
    Kuang, Anren
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [5] Outcomes of Children and Adolescents with Well-Differentiated Thyroid Carcinoma and Pulmonary Metastases Following 131I Treatment: A Systematic Review
    Pawelczak, Melissa
    David, Raphael
    Franklin, Bonita
    Kessler, Marion
    Lam, Leslie
    Shah, Bina
    [J]. THYROID, 2010, 20 (10) : 1095 - 1101
  • [6] Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma
    Prinsen, Hester T.
    Hesselink, Esther N. Klein
    Brouwers, Adrienne H.
    Plukker, John T. M.
    Sluiter, Wim J.
    van der Horst-Schrivers, Anouk N. A.
    van Imhoff, Gustaaf W.
    Links, Thera P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10): : 3911 - 3917
  • [7] FDG PET Predicts the Effects of 131I and Prognosis for Patients with Bone Metastases from Differentiated Thyroid Carcinoma
    Wang, Danyang
    Bai, Yongli
    Huo, Yanlei
    Ma, Chao
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 13223 - 13232
  • [8] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [9] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [10] Effect of 131I therapy on pulmonary function from pulmonary metastases with differentiated thyroid cancer
    Chen, Pan
    Wei, Ouyang
    Feng, Huijuan
    Wu, Juqing
    Wang, Jing
    Deng, Yuying
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345